The presence of selected pharmaceuticals and the antimicrobial triclosan in drinking water in Ontario, Canada

Water Quality Research Journal of Canada

Volumn 42, Issue 2, 2007, Pages 130-137

  Servos, Mark R ^a,b   Smith, Martha ^a   McInnis, Rodney ^a   Burnison, B Kent ^a   Lee, Bill H ^a   Seto, Peter ^a   Backus, Sean ^a  

^a ENVIRONMENT CANADA   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Drinking water; Ontario; Pharmaceuticals; Source water; Triclosan; Water treatment

Indexed keywords

CONTAMINATION; DRUG PRODUCTS; EFFLUENTS; REMOVAL; WATER ANALYSIS; WATER TREATMENT;

SEWAGE EFFLUENT; TRICLOSAN;

POTABLE WATER;

CONTAMINATION; DRUG PRODUCTS; EFFLUENTS; POTABLE WATER; REMOVAL; WATER ANALYSIS; WATER TREATMENT;

ANTIMICROBIAL ACTIVITY; CONCENTRATION (COMPOSITION); DETECTION METHOD; DRINKING WATER; DRUG; EFFLUENT; ENVIRONMENTAL ASSESSMENT; RIVER POLLUTION; SEWAGE OUTFALL; WATER QUALITY; WATER TREATMENT;

CANADA; EURASIA; EUROPE; NORTH AMERICA; ONTARIO [CANADA]; UNITED STATES;

EID: 38949089995     PISSN: 12013080     EISSN: None     Source Type: Journal    
DOI: 10.2166/wqrj.2007.016     Document Type: Article

References (45)

1. Ashton D, Hilton M, Thomas KV. 2004. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333:167-84
2. Boyd GL, Palmeri JM, Zhang S, Grimm DA. 2004. Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA. Sci. Total Environ. 33:137-48.
3. Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee H-B. 2006. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 25:2163-2176.
4. Buser H-R, Müller AM, Theobald N. 1998. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci.Technol. 32:188-92.
5. Christensen FM. 1998. Pharmaceuticals in the environment - a human risk? Regulat. Toxicol. Pharmacol. 28:212-21.
6. Clara M, Strenn B, Kreuzinger N. 2004. Carbamazepine as a possible anthropengic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 38:947-54.
7. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 107:907-38.
8. Gross B, Montgomery-Brown J, Naumann A, Reinhard M. 2004. Occurrence and fate of pharmaceuticals and alkyphenol ethoxylates, metabolites in an effluent-dominated river and wetland. Environ. Toxicol. Chem. 23:2074-83.
9. Halling-Sorenson B, Nielsen SN, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgensen SC. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere 36:357-93.
10. Heberer Th. 2002a. Occurrence, fate and removal of pharmaceutical residues in aquatic environment: A review of recent research data. Toxicol. Lett. 131:5-17.
11. Heberer Th. 2002b. Tracking persistent pharmaceutical residues from municipal sewage to drhiking water. J. Hydrol. 266:175-89.
12. Heberer Th, Dünnbier U, Reilich Ch, Stan H-J. 1997. Detection of drugs and drug metabolites in groundwater samples of a drinking water treatment plant. Fresenius Environ. Bull. 6:438-43.
13. Heberer Th, Reddersen K, Mechlinski A. 2002. From municipal sewage to drinking water: Fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci. Technol. 46(3):81-8.
14. Hua W, Bennnett W, Letcher RJ. 2006a. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 40:2259-2266.
15. Hua WY, Bennett ER, Maio X-S, Metcalfe CD, Letcher R.J. 2006b. Seasonal effects on pharmaceuticals and Striazines herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit River. Environ. Toxicol. Chem. 9:2356-2365.
16. Huber MM, Canonica S, Park G-Y, Gunten. 2003. UV. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37:1016-24.
17. Koplin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic contaminants in U.S. stream, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 36:1202-11.
18. Koplin DW, Skopec M, Meyer MT, Furlong ET, Zaugg SD. 2004. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci. Total Environ. 328: 119-30.
19. Lee B-H, Peart TE, Carron JM, Tse H. 1991. Chemical derivatization analysis of pesticide residues. Part XI. An improved method for the determination and confirmation of acidic herbicides in water. J. Assoc. Off. Anal. Chem. 74: 835-42.
20. Lee HB, Sarafin K, Peart TE, Svoboda ML. 2003. Acidic pharmaceuticals in sewage - Methodology, stabifirytest, occurrence, and removal from Ontario samples. Water Qual. Res.J. Can. 38:667-682.
21. Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P, 2006. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci. Total Environ. 367:544-558.
22. Lissemore L, Hoa C, Yang P, Sibley PK, Mabury S and Solomon KR. 2006. An exposure assessment for selected pharmaceuticals within a watershed in southern Ontario. Chemosphere 64:544-558.
23. Metcalfe CD, Koenig BG, Bennie DT, Servos MR, Ternes TA, Hirsch R. 2003a. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ.Toxicol. Chem. 22:2872-80.
24. Metcalfe CD, Metcalfe TL, Kiparissis Y, Koenig BG, Khan C, Hughes RJ, Croley TR, March RE, Potter T. 2001. The estrogenic potency of chemicals in sewage treatment plant effluents as determined by in vivo assays with the Japanese medaka, Oryzias latipes. Environ. Toxicol. Chem. 20:297-308.
25. Metcalfe CD, Miao X-S, Koenig BG, Struger J. 2003b. Distribution of acidic and neutral drugs in surface water near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 22:2881-2889.
26. Miao X-S, Koenig BG, Metcalfe CD. 2002. Analysis of acidic drugs in the effluents of sewage treatment plants using liquid-chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 952:139-47.
27. Miao X-S, Metcalfe CD. 2003a. Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr A 998: 133-41.
28. Miao X-S, Metcalfe CD. 2003b. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal. Chem. 75:3731-38.
29. Pinkston KE, Sedlak DL. 2004. Transformation of aromatic ether- and amine-containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 38:4019-25.
30. Rogers IH, Birtwell IK, Kruznyski GM. 1986. Organic extractables in municipal wastewater of Vancouver, British Columbia. Water Poll. Res. J. Canada 21: 187-204.
31. Sacher F, Lange FF, Brauch H-J, Blankenhorn I. 2001. Pharmaceuticals in groundwaters, Analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany. J. Chromatogr. A 938:199-210.
32. Servos MR, Bennie DT, Burnison BK, Jurkovic A, McInnis R, Neheli T, Schnell A, Seto P, Smyth SA, Ternes TA. 2005. Removal of hormones, 17β-estradiol and estrone, in Canadian municipal wastewater treatment plants. Sci. Total Environ. 336:155-70.
33. Servos AM, Innes E, Given J, Ostapyk K, Topp E, McInnis R, Starodub ME. 2002. Assessment and Management of Pharmaceuticals and Personal Care Products. In the Canadian Environment Proceedings of a Multi-Stakeholder Workshop, Feb. 24-27,2002. Environment Canada and Health Canada Special Publication.
34. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AM, Reissman DB. 2004. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 329:99-113.
35. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 12:3245-60.
36. Ternes TA, Kreckel P, Mueller J. 1999. Behavior and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 225:91-101.
37. Ternes, TA, Meisenheimer M, Mcdowell K, Sacher F, Brauch H-J, Haist-Gulde B Preuss G, Wilme U, Zulei-Seibert N. 2002. Removal of pharmaceuticals during drinking water treatment. Environ. Sci Technol. 36:3855-63.
38. Ternes TA, Stüber J, Herrmann N, McDowell, D, Reid A, Kampmann M, Teiser B. 2003. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Reg. 37:1976-82.
39. Ternes TA, Stumpf M, Mueller I, Haberer K, Vrdken R-D, Servos M. 1999. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 225: 81-90.
40. Thomas KV, Hilton MJ. 2004. The occuxrence of selected human pharmaceutical compounds in UK estuaries. Marine Poll. Bull. 49:436-44
41. Webb S. 2001. A data-based perspective on the environmental risk assessment of human pharmaceuticals III-Indirect human exposure, p. 221-230. In Kümmerer K, (ed.), Pharmaceuticals in the environment-sources, fate, effects and risks. Springer, Berlin.
42. Webb S, Ternes T, Gibert M, Olejniczak K. 2003. Indirect human exposure to pharmaceuticals via drinking water. Toxicol. Lett. 142:157-67.
43. Wiegel S, Aulinger A, Brockmeyer R, Hams H, Löffler J, Reincke H, Schmidt R, Stachel B, von Tümpling W, Wanke WA. 2004. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57:107-26.
44. Wieget S, Berger U, Jensen E, Kallenborn R, norcsen H, Hühnerfuss H. 2004b. Determination o f selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56:583-92.
45. Zwiener C, Frimmel FH. 2000. Oxidative treatment of pharmaceuticals in water. Water Res. 34:1881-85.